Adverse reactions to monoamine oxidase inhibitors. Part ii. treatment correlates and clinical management

Journal of Clinical Psychopharmacology

Volumn 5, Issue 1, 1985, Pages 2-9

  Rabkin, Judith G ^a,b   Quitkin, Frederic M ^a,b   McGrath, Patrick ^a,b   Harrison, Wilma ^a,b   Tricamo, Elaine ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXAPINE; CHLORPROMAZINE; FLUDROCORTISONE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; PHENOXYBENZAMINE; PHENTOLAMINE; PHENTOLAMINE MESYLATE; PLACEBO; PSEUDOEPHEDRINE; PSEUDOEPHEDRINE PLUS TRIPROLIDINE; TRANYLCYPROMINE;

ADVERSE DRUG REACTION; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DEPRESSION; DRUG THERAPY; HUMAN; HYPERTENSION; HYPOMANIA; INTOXICATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PSYCHOLOGICAL ASPECT; REPRODUCTIVE TOXICITY; SEXUAL DYSFUNCTION; THERAPY; WEIGHT GAIN;

ADULT; BIPOLAR DISORDER; BODY WEIGHT; FEMALE; HUMANS; HYPERTENSION; IMIPRAMINE; IMPOTENCE; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PHENELZINE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TIME FACTORS; TRANYLCYPROMINE;

EID: 0021944194     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/00004714-198502000-00002     Document Type: Article

References (22)

1. Rabkin J, Quitkin F, Harrison W, Tricamo E, McGrath P. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study. J Clin Psychopharmacol 1984;4:270–8.
2. Liebowitz M, Quitkin F, Stewart J, et al. Phenelzine versus imipramine in atypical depression: a preliminary report. Arch Gen Psychiatry 1984;41:669–77.
3. Sheehan D, Claycomb JB, Kouretas N. Monoamine oxidase inhibitors: prescription and patient management. Int J Psychiatry Med 1980–81;1:99–121.
4. Klein DF, Gittelman R, Quitkin F, Rifkin A. Diagnosis and drug treatment of psychiatric disorders: adults and children. Baltimore: Williams & Wilkins, 1980.
5. Glassman AH, Bigger JT, Giardina E, et al. Clinical characteristics of imipramine induced orthostatic hypotension. Lancet 1979;1:468–72.
6. Kronig MH, Roose SP, Walsh BT, Woodring S, Glassman AH. Blood pressure effects of phenelzine. J Clin Psychopharmacol 1983;3:307–10.
7. Roose SP, Glassman AH, Siris S, Walsh BT, Bruno RL, Wright LB. Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmacol 1981;1:316–9.
8. Munjack D. The treatment of phenelzine-induced hypotension with salt tablets: case report. J Clin Psychiatry 1984;45:89–90.
9. Bunney WE. Psychopharmacology of the switch process in affective illness. In: Lipton MA, DiMascio A, Killam KF, eds. Psychopharmacology: a generation of progress. New York: Raven Press, 1978:1249–59.
10. Murphy DL. The behavioral toxicity of monoamine oxidase-inhibiting antidepressants. Adv Pharmacol Chemotherap 1977;14:71–105.
11. Pickar D, Murphy DL, Cohen R, et al. Selective and nonselective monoamine oxidase inhibitors: behavioral disturbances during their administration to depressed patients. Arch Gen Psychiatry 1982;39:535–40.
12. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979;36:555–60.
13. Lewis J, Winokur G. The induction of mania. Arch Gen Psychiatry 1982;39:303–6.
14. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics, 6th ed. New York: Macmillan, 1980:391–447.
15. The psychiatrist’s compendium of drug therapy, 1982/1983. New York: Biomedical Information Corp., 1982.
16. Physicians’ desk reference, 34th ed. Oradell, NJ: Medical Economics Co., 1980.
17. Lesko L, Stotland N, Segraves RT. Three cases of female anorgasmia associated with MAOIs. Am J Psychiatry 1982;139:1353–5.
18. Christenson R. MAOI’s, anorgasmia and weight gain (letter). Am J Psychiatry 1983;140:1280.
19. Drugs that cause sexual dysfunction. Med Lett 1983;25:73–6.
20. Mitchell JE, Popkin MK. Antidepressant drug therapy and sexual dysfunction in men: a review. J Clin Psychopharmacol 1983;3:76–9.
21. Shen WW, Mallya A. MAOI-induced inhibited female orgasm (letter). Am J Psychiatry 1983;140:1275.
22. Gross MD. Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants. Am J Psychiatry 1982;139:1193–4.